All data are based on the daily closing price as of October 9, 2025
h
Hanmi Science Co.
008930.KO
27.19 USD
-0.19
-0.69%
Overview
Last close
27.19 usd
Market cap
1.84B usd
52 week high
37.77 usd
52 week low
17.04 usd
Target price
22.82 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.9477
Price/Book Value
2.9546
Enterprise Value
1.91B usd
EV/Revenue
2.0473
EV/EBITDA
31.9503
Key financials
Revenue TTM
933.63M usd
Gross Profit TTM
198.63M usd
EBITDA TTM
36.02M usd
Earnings per Share
N/A usd
Dividend
0.21 usd
Total assets
1.02B usd
Net debt
96.69M usd
About
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems. The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.